British Journal of Ophthalmology 2006;90:773-777
EXTENDED REPORT
Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease
1 Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
2 Department of Ophthalmology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan
3 Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
Correspondence to:
Correspondence to:
Yutaka Kawakami
MD, PhD, Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjyukuku, Tokyo, 160-8582, Japan; yutakawa{at}sc.itc.keio.ac.jp
Aim: To isolate autoantigens possibly involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
Methods: Autoantigens recognised by immunoglobulin G antibodies (IgG Ab) in sera from VKH patients were isolated by screening the lambda phage cDNA libraries made from melanocytes and a highly pigmented melanoma cell line with the patients sera. Presence of IgG specific for the autoantigens in sera from patients with various panuveitis and healthy individuals was evaluated. Relation between the specific IgG and various clinicopathological features was examined.
Results: KU-MEL-1 was found to be one of the 81 isolated positive clones representing 35 distinct genes, which is a previously isolated melanoma antigen preferentially expressed in melanocytes. The IgG Ab specific for KU-MEL-1 was detected in sera from patients with VKH in significantly higher amounts than in sera from patients with Behçets disease, sarcoidosis, and from healthy individuals. Positive serum KU-MEL-1 Ab was significantly associated with HLA-DRB1*0405 and male VKH patients.
Conclusion: KU-MEL-1 was identified as a new autoantigen for VKH. The highly frequent induction of IgG Ab for KU-MEL-1 in HLA-DRB1*0405 positive VKH patients may suggest the possible involvement of KU-MEL-1 specific CD4+ T cells in the pathogenesis of VKH, suggesting the possible use in the development of diagnostic and therapeutic treatments for VKH patients.
Abbreviations: Ab, antibody; CTL, cytotoxic T cells; IgG, immunoglobulin G; LEDGF, lens epithelium derived growth factor; PBMC, peripheral blood mononuclear cells; PCR, polynerase chain reaction; pfu, plaque forming units; SRD, serous retinal detachment; UACA, uveal autoantigen with coiled coil domains and ankyrin repeats; VKH, Vogt-Koyanagi-Harada
Keywords: Vogt-Koyanagi-Harada disease; KU-MEL-1; DNA cloning; autoimmunity; uveitis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
